Studies in breast cancer suggest blockade of CSF-1 limits macrophage infiltration and improves response to chemotherapy (43–45), and another group (46) found that targeting TAMs by CSF-1R inhibition in a transgenic breast cancer mice model stimulated an intratumoral type I IFN response, enhancing the efficacy of platinum-based chemotherapy. This evidence concerns the gene CSF1R and breast cancer.